SCOUT INVESTMENTS, INC. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 154 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
SCOUT INVESTMENTS, INC. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,995,430
-21.3%
131,192
-2.8%
0.05%
-11.5%
Q2 2023$2,534,081
-35.8%
135,007
-2.9%
0.05%
-35.0%
Q1 2023$3,945,075
-4.0%
139,058
-1.1%
0.08%
-4.8%
Q4 2022$4,110,966
+8.8%
140,642
-1.6%
0.08%
+7.7%
Q3 2022$3,778,000
-42.2%
142,984
-2.8%
0.08%
-39.5%
Q2 2022$6,533,000
-22.0%
147,034
-13.1%
0.13%
-3.7%
Q1 2022$8,376,000
-2.9%
169,238
-0.1%
0.13%
+7.2%
Q4 2021$8,629,000
-10.7%
169,466
-2.2%
0.12%
-13.2%
Q3 2021$9,666,000
+27.7%
173,286
-2.1%
0.14%
+27.4%
Q2 2021$7,572,000
+24.0%
176,913
+21.0%
0.11%
+22.8%
Q1 2021$6,104,000
-0.7%
146,249
+10.8%
0.09%
-18.6%
Q4 2020$6,146,000
+12.6%
131,969
+2.7%
0.11%
-6.6%
Q3 2020$5,457,000
+34.8%
128,469
+52.3%
0.12%
+24.7%
Q2 2020$4,047,000
+3.8%
84,355
-0.5%
0.10%
-16.4%
Q1 2020$3,898,000
-27.8%
84,741
-5.7%
0.12%
+11.5%
Q4 2019$5,398,000
+4.5%
89,850
-1.6%
0.10%
+1.0%
Q3 2019$5,168,000
-6.1%
91,350
-7.5%
0.10%
-2.8%
Q2 2019$5,502,000
+98.1%
98,810
+79.7%
0.11%
+86.0%
Q1 2019$2,777,000
+22.4%
54,995
-2.3%
0.06%0.0%
Q4 2018$2,269,000
-27.3%
56,311
+25.1%
0.06%
-10.9%
Q3 2018$3,121,00045,0220.06%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders